HUMAPEN Trademark

Trademark Overview

On Wednesday, June 9, 1999, a trademark application was filed for HUMAPEN with the United States Patent and Trademark Office. The USPTO has given the HUMAPEN trademark a serial number of 75724618. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2024. This trademark is owned by Eli Lilly and Company. The HUMAPEN trademark is filed in the Medical Instrument Products category with the following description:

insulin delivery devices, namely, syringes
humapen

General Information

Serial Number75724618
Word MarkHUMAPEN
Filing DateWednesday, June 9, 1999
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2024
Registration Number2767043
Registration DateTuesday, September 23, 2003
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 14, 1999

Trademark Statements

Goods and Servicesinsulin delivery devices, namely, syringes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2024
Primary Code010
First Use Anywhere DateMonday, August 31, 1998
First Use In Commerce DateMonday, August 31, 1998

Trademark Owner History

Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Tuesday, August 8, 2000SOU EXTENSION 1 FILED
Tuesday, September 14, 1999ASSIGNED TO EXAMINER
Wednesday, September 15, 1999ASSIGNED TO EXAMINER
Tuesday, September 21, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 12, 1999NOTICE OF PUBLICATION
Tuesday, December 14, 1999PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 2, 2000SOU EXTENSION 1 GRANTED
Tuesday, September 3, 2002SOU EXTENSION 5 FILED
Wednesday, February 28, 2001SOU EXTENSION 2 FILED
Wednesday, March 21, 2001SOU EXTENSION 2 GRANTED
Friday, August 10, 2001SOU EXTENSION 3 FILED
Tuesday, August 28, 2001SOU EXTENSION 3 GRANTED
Monday, March 4, 2002PAPER RECEIVED
Monday, March 4, 2002SOU EXTENSION 4 FILED
Friday, March 22, 2002SOU EXTENSION 4 GRANTED
Tuesday, September 3, 2002PAPER RECEIVED
Thursday, January 23, 2003PAPER RECEIVED
Friday, March 28, 2003SOU EXTENSION 5 GRANTED
Tuesday, September 23, 2003REGISTERED-PRINCIPAL REGISTER
Friday, September 15, 2006REVIEW OF CORRESPONDENCE COMPLETE
Thursday, January 23, 2003USE AMENDMENT FILED
Thursday, January 23, 2003STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 17, 2003CASE FILE IN TICRS
Friday, July 18, 2003ASSIGNED TO EXAMINER
Tuesday, July 22, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 8, 2004PAPER RECEIVED
Monday, September 30, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, September 10, 2009TEAS SECTION 8 & 15 RECEIVED
Wednesday, September 23, 2009CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 23, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, September 11, 2013TEAS SECTION 8 & 9 RECEIVED
Saturday, September 14, 2013POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Friday, September 20, 2013TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, September 30, 2013REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Monday, September 30, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, September 30, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 23, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 5, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

humapen syringes namely devices delivery insulin